FGF2 and cardiac hypertrophy: The exaggerated cardiac hypertrophy and fibrosis observed in a mouse model subjected to pressure overload correlated with significantly elevated cardiac Hi-FGF-2 levels, pointing to Hi-, rather than Lo-FGF-2 as an agent of pathological change[18].